Efinaconazole 10% solution was found to be a safe and effective treatment of chronic fungal nail infections among patients with skin of color, according to a study published in the Journal of Drugs in ...
A New Approach Enabling Physicians to Treat Toenail Fungus at the Point-of-Care HSG 42 is highly differentiated. It is ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. No prescription was prescribed in 82% of the dermatology ...
WASHINGTON, Jan. 31, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug ...
Moberg Pharma is developing MOB-015, which is believed to be the most successful therapy amongst all the other expected drug candidates and shall account for the highest Onychomycosis market revenue ...
Onychomycosis is the most common disease of nails, with a prevalence of up to 14% in Western adult populations. Whereas tinea unguium refers strictly to dermatophyte fungal infection of the nail plate ...
LOS ALTOS, Calif.--(BUSINESS WIRE)--TOPICA Pharmaceuticals, Inc., a privately held biotechnology company, today announced that it’s ready to advance its 10% solution of luliconazole into Phase 3 ...
Hosted on MSN
Should you be concerned about toenail fungus?
Subungual onychomycosis is the most common type of toenail fungus and affects the nail bed and underside of the nail. White superficial onychomycosis causes white spots and flaky patches on the ...
DUBAI, UAE / ACCESSWIRE / September 1, 2020 / According to a new market study by Future Market Insights (FMI), the global onychomycosis treatment market will expand at a healthy rate between 2018 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results